Nacif Lucas Souto, Zanini Leonardo Yuri, Waisberg Daniel Reis, Costa Dos Santos João Paulo, Pereira Juliana Marquezi, Pinheiro Rafael Soares, Rocha-Santos Vinicius, Martino Rodrigo Bronze, Arantes Rubens Macedo, Ducatti Liliana, Haddad Luciana, Galvão Flávio Henrique, Andraus Wellington, Carneiro-D'Albuquerque Luiz
Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Transplant Proc. 2020 Jun;52(5):1299-1302. doi: 10.1016/j.transproceed.2020.02.073. Epub 2020 Mar 25.
Living donor liver transplant (LDLT) is a well-established treatment for end-stage liver disease. A better recipient selection and hemodynamic evaluation may improve transplant outcomes. The aim of this study was to establish recipient parameters that could enhance the results of adult-to-adult LDLT.
We performed a retrospective study of all adult-to-adult LDLTs from a single center between January 2006 and December 2018. Variables analyzed included demographic and clinical parameters, laboratory tests, performance of intraoperative temporary portocaval shunt (TPCS), graft weight/recipient weight ratio (GW/RW), preoperative portal vein thrombosis (PVT), previous major abdominal surgery, and patient survival. Patients were divided in 2 groups according to GW/RW (0.8% cutoff point).
A total of 92 adult-to-adult LDLTs were analyzed, encompassing 53 male patients (57.6%). Mean Model for End-Stage Liver Disease score was 13.97 (SD, 4.74), and 57 patients (61.95%) had Child-Pugh-Turcotte score B. Mean GW/RW was 1.1% (SD, 0.37%). Group 1 with GW/RW > 0.8% (n = 74) and group 2 with it ≤ 0.8% (n = 13) presented mean GW/RW of 1.14% (SD, 0.24%) and 0.69% (SD, 0.09%) and P < .01, respectively. Eighteen patients (19.56%) presented PVT, with a worse survival than those without PVT (P = .006). Sixteen patients (17.39%) with previous major abdominal or biliary operations also presented higher mortality (P = .341). Forty-six (50%) intraoperative TPCSs were performed with a better 1- and 3-year patient survival. Receiver operating characteristic curve analysis showed PVT area under the curve of 0.701 (95% CI, 0.526-0.876; P = .018), positive predictive value of 0.69, and negative predictive value of 0.62. Multivariate analysis showed important risk regarding PVT (odds ratio, 6.160; 95% CI, 1.566-24.223; P = .004) and retransplant (odds ratio, 4.452; 95% CI, 0.843-23.503; P = .06).
Better recipient selection without PVT or previous major abdominal surgery, an adequate GW/RW, and intraoperative TPCS with hemodynamic modulation significantly improve outcomes of adult-to-adult LDLT.
活体供肝肝移植(LDLT)是治疗终末期肝病的一种成熟疗法。更好的受者选择和血流动力学评估可能会改善移植效果。本研究的目的是确定能够提高成人对成人LDLT效果的受者参数。
我们对2006年1月至2018年12月期间来自单一中心的所有成人对成人LDLT进行了回顾性研究。分析的变量包括人口统计学和临床参数、实验室检查、术中临时门腔分流术(TPCS)的实施情况、移植物重量/受者体重比(GW/RW)、术前门静脉血栓形成(PVT)、既往腹部大手术史以及患者生存率。根据GW/RW(截断点为0.8%)将患者分为两组。
共分析了92例成人对成人LDLT,其中男性患者53例(57.6%)。终末期肝病模型平均评分为13.97(标准差,4.74),57例患者(61.95%)的Child-Pugh-Turcotte评分为B级。平均GW/RW为1.1%(标准差,0.37%)。GW/RW>0.8%的第1组(n = 74)和GW/RW≤0.8%的第2组(n = 13)的平均GW/RW分别为1.14%(标准差,0.24%)和0.69%(标准差,0.09%),P<0.01。18例患者(19.56%)出现PVT,其生存率低于未出现PVT的患者(P = 0.006)。16例有既往腹部或胆道大手术史的患者(17.39%)的死亡率也较高(P = 0.341)。46例(50%)患者术中进行了TPCS,其1年和3年患者生存率更高。受试者工作特征曲线分析显示,PVT的曲线下面积为0.701(95%CI,0.526 - 0.876;P = 0.018),阳性预测值为0.69,阴性预测值为0.62。多因素分析显示,PVT(比值比,6.160;95%CI,1.566 - 24.223;P = 0.004)和再次移植(比值比,4.452;95%CI,0.843 - 23.503;P = 0.06)是重要风险因素。
选择没有PVT或既往腹部大手术史的更好的受者、适当的GW/RW以及术中进行血流动力学调节的TPCS可显著改善成人对成人LDLT的效果。